Subgroup analysis indicated that the prevalence of NAFLD in type 2 diabetes mellitus patients differed by total cholesterol, TG, BMI, HbA1c and HDL, LDL, AST, and ALT. The gene discussed is GPT; the disease is type 2 diabetes mellitus.